| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥36.6B | ¥35.7B | +2.7% |
| Operating Income | ¥-1.3B | ¥-0.6B | -111.5% |
| Ordinary Income | ¥-0.9B | ¥-0.1B | -528.6% |
| Net Income | ¥-1.0B | ¥-0.2B | -499.9% |
| ROE | -9.5% | -1.6% | - |
FY2026 Q3 results show revenue of 36.6 billion yen (YoY +2.7%) with operating loss of 1.3 billion yen (prior year loss of 0.6 billion yen, YoY -111.5%), ordinary loss of 0.9 billion yen (prior year loss of 0.1 billion yen, YoY -528.6%), and net loss of 1.0 billion yen (prior year loss of 0.2 billion yen, YoY -499.9%). While top-line growth remained modest at 2.7%, profitability deteriorated significantly across all levels with operating margin declining to -3.5%. The company operates in sanitary equipment manufacturing and distribution as a single business segment.
Revenue increased 2.7% YoY to 36.6 billion yen, indicating stable but modest demand in the sanitary equipment business. However, gross profit of 5.8 billion yen yielded a gross margin of only 15.8%, which is substantially below typical manufacturing sector benchmarks. Selling, general and administrative expenses totaled 7.1 billion yen, exceeding gross profit and directly causing the operating loss of 1.3 billion yen. Operating margin deteriorated to -3.5% from -1.7% in the prior year. Non-operating income of 0.67 billion yen, primarily comprising dividend income of 0.16 billion yen, partially offset operating losses but was insufficient to achieve profitability. Interest expense of 0.11 billion yen further pressured earnings with an interest burden coefficient of 0.703. The gap between operating loss of 1.3 billion yen and ordinary loss of 0.9 billion yen reflects the 0.4 billion yen net contribution from non-operating items. Extraordinary gains from fixed asset disposals provided minimal relief. Net loss expanded from 0.2 billion yen to 1.0 billion yen YoY, driven by deepening operating losses and ongoing financial costs. This represents a revenue up, profit down pattern with structural profitability challenges requiring cost structure reform.
The company operates a single segment in sanitary equipment manufacturing and distribution, with no segmented operating profit disclosed.
[Profitability] ROE of -9.5% reflects negative profitability amplified by high financial leverage. Dupont decomposition shows net profit margin of -2.6%, asset turnover of 0.811 times, and financial leverage of 4.48 times, with the negative margin being the primary driver of negative returns. Operating margin of -3.5% and gross margin of 15.8% both indicate structural profitability challenges, with SG&A expenses exceeding gross profit. [Cash Quality] Cash and deposits of 4.02 billion yen provide 0.35 times coverage of short-term liabilities of 11.50 billion yen, indicating constrained liquidity. Working capital of 5.10 billion yen includes electronically recorded monetary claims of 5.26 billion yen, accounts receivable of 5.97 billion yen, and product inventory of 7.26 billion yen. Days inventory outstanding of 122 days and cash conversion cycle of 143 days reflect inefficient working capital management. [Investment Efficiency] Asset turnover of 0.811 times is in line with industry median of 0.82 times, suggesting reasonable asset utilization despite profitability issues. Investment securities increased 35.0% YoY from 4.05 billion yen to 5.46 billion yen, introducing mark-to-market volatility risk to equity. [Financial Health] Equity ratio of 22.3% stands well below the industry median of 52.3%, reflecting high leverage. Current ratio of 123.9% falls short of the 150% safety threshold. Debt-to-equity ratio of 3.48 times significantly exceeds the industry median of 1.90 times, with short-term debt representing 68.0% of total liabilities. Interest coverage is negative at -11.96 times as operating profit fails to cover interest expense.
Cash flow statement details are limited in the quarterly disclosure. Cash and deposits of 4.02 billion yen face pressure from short-term borrowings of 11.50 billion yen and long-term debt of 5.41 billion yen, creating significant refinancing risk given the 68% short-term debt concentration. Working capital movements show accounts receivable turnover of 46 days and payables turnover of 30 days, with the 143-day cash conversion cycle indicating substantial cash tied up in operations. The 35% increase in investment securities to 5.46 billion yen represents a material use of funds while operating losses persist. With cash covering only 0.35 times short-term liabilities, liquidity management remains critical. The company's ability to manage debt rollovers and improve operating cash generation through inventory reduction and receivables collection will be essential to maintaining financial stability.
Ordinary loss of 0.9 billion yen versus operating loss of 1.3 billion yen reflects net non-operating income of approximately 0.4 billion yen, primarily comprising dividend income of 0.16 billion yen and other financial income. Non-operating income represents approximately 1.8% of revenue, providing marginal support to bottom-line results but insufficient to offset core operating losses. The presence of extraordinary gains from fixed asset disposals indicates non-recurring factors that do not represent sustainable earnings power. With operating cash flow data unavailable in the quarterly disclosure, assessment of cash-backed earnings quality is limited, though the negative net income and constrained cash position of 4.02 billion yen suggest earnings are not generating adequate cash. The structural nature of operating losses, driven by SG&A expenses exceeding gross profit, indicates earnings quality concerns that require fundamental business model improvements rather than reliance on non-operating or extraordinary items.
Full-year guidance projects revenue of 48.0 billion yen (down 0.9% YoY), operating income of 0.10 billion yen, and net income of 0.10 billion yen with EPS of 2.7 yen. Q3 cumulative revenue of 36.6 billion yen represents 76.3% progress against the full-year target, which is ahead of the standard 75% pace for Q3. However, with Q3 cumulative operating loss of 1.3 billion yen versus full-year operating income guidance of 0.10 billion yen, the company requires a substantial turnaround in Q4 to achieve profitability, representing execution risk. The implied Q4 operating income needed would be approximately 1.4 billion yen to offset cumulative losses and meet guidance, requiring significant quarter-on-quarter improvement in gross margin or SG&A reduction that has not been demonstrated in the year-to-date trend.
The company declared zero dividend for the period, consistent with the full-year guidance of zero dividend per share. With net loss of 1.0 billion yen, dividend payout is not sustainable under current profitability levels. No share buyback activity was disclosed. The zero shareholder return policy reflects prioritization of financial stability and debt management given the high leverage position with debt-to-equity ratio of 3.48 times and negative profitability. Until operating performance improves and financial leverage normalizes, resumption of shareholder distributions appears unlikely.
Refinancing risk from short-term debt concentration represents the most critical near-term risk, with 11.50 billion yen in short-term borrowings against 4.02 billion yen in cash, creating 68% short-term liability ratio and potential rollover pressure. Operating margin deterioration driven by SG&A expenses of 7.1 billion yen exceeding gross profit of 5.8 billion yen indicates structural cost issues that, if unaddressed, could lead to continued losses and equity erosion from the current 10.1 billion yen base. Working capital inefficiency with 122 days inventory outstanding and 143-day cash conversion cycle ties up approximately 5.1 billion yen in operating working capital, limiting cash generation and increasing reliance on external financing in a loss-making environment.
[Industry Position] (Reference - Proprietary Analysis) The company's financial metrics show significant underperformance relative to industry peers in the sanitary equipment and related manufacturing sector. Profitability: ROE of -9.5% substantially underperforms the industry median of 8.1%, with net profit margin of -2.6% versus industry median of 6.5% and operating margin of -3.5% versus industry median of 4.7%, indicating core business profitability challenges. Financial Health: Equity ratio of 22.3% falls well below the industry median of 52.3%, while debt-to-equity ratio of 3.48 times significantly exceeds the industry median of 1.90 times, reflecting elevated financial leverage and vulnerability. Current ratio of 1.24 times lags the industry median of 2.03 times, indicating weaker liquidity positioning. Efficiency: Asset turnover of 0.811 times aligns closely with industry median of 0.82 times, suggesting comparable asset utilization despite profitability gaps. Revenue growth of 2.7% compares to industry median of 5.7%, showing slower top-line expansion. Working capital metrics lag materially with inventory turnover of 122 days versus industry median of 35 days, and receivables turnover of 46 days near industry median of 47 days but combined into a 143-day cash conversion cycle well above industry norms. (Industry: Sanitary Equipment Manufacturing (10 companies), Comparison: 2025-Q3 period, Source: Proprietary analysis)
The company demonstrates stable revenue generation with 2.7% growth but faces acute profitability and leverage challenges requiring operational restructuring. The structural mismatch where SG&A expenses exceed gross profit by 1.3 billion yen creates persistent operating losses that cannot be offset by non-operating income, indicating the need for fundamental cost reduction or gross margin improvement through product mix optimization or pricing power enhancement. Financial structure presents material risk with debt-to-equity of 3.48 times and 68% short-term debt concentration against limited cash coverage of 0.35 times, creating refinancing vulnerability that could be exacerbated by continued losses eroding the 10.1 billion yen equity base. Working capital efficiency improvement through inventory reduction from 122 days and acceleration of the 143-day cash conversion cycle represents a tangible path to cash generation that could partially address liquidity constraints without requiring external financing. The ambitious Q4 turnaround required to meet full-year guidance of 0.10 billion yen operating income from a Q3 cumulative loss position warrants close monitoring of execution and cost control initiatives.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.